RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Substantial Evidence: Substantially Black and White

Substantial Evidence: Substantially Black and White

Posted 01 August 2011 | By

Those of us who work in the regulatory advertising and promotions field often describe the regulations under which we operate and the US Food and Drug Administration (FDA) interpretation of those regulations as "gray." We continuously scour FDA enforcement websites hoping to gain an inkling of what FDA's current thinking is on a wide range of advertising and promotion topics such as risk presentation and social media. We attend conferences and hang on each regulator's every word looking to be enlightened and move from gray to black and white.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.